Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid ArthritisGlobeNewsWire • 02/02/21
Earnings Preview: Myriad Genetics (MYGN) Q2 Earnings Expected to DeclineZacks Investment Research • 01/28/21
Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in JapanGlobeNewsWire • 01/19/21
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Myriad Genetics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 01/18/21
Myriad Genetics Receives First Reimbursement Decision for myChoice® Diagnostic System in Japan, Enabling Women with Ovarian Cancer to Benefit from Treatment with Zejula®GlobeNewsWire • 01/08/21
Stocks making the biggest moves after the bell: Cal-Maine Foods, Myriad Genetics & moreCNBC • 01/05/21
Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International OperationsGlobeNewsWire • 01/05/21
New Study Provides Personalized Breast Cancer Risk Information for Women with ATM Gene MutationsGlobeNewsWire • 12/11/20
IBD Rating Upgrades: Myriad Genetics Flashes Improved Technical StrengthInvestors Business Daily • 12/04/20
Suffering in Silence: Two-Thirds of Older Adults Say They Won't Treat Their DepressionGlobeNewsWire • 11/17/20
Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and ChinaGlobeNewsWire • 11/16/20
New Data Show Importance of Vectra® Testing and Biomarkers in Predicting Risk for Cardiovascular Events in Patients with Rheumatoid ArthritisGlobeNewsWire • 11/11/20
Myriad Genetics' (MYGN) CEO Paul Diaz on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer Prognostic TestGlobeNewsWire • 10/16/20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate Governance Changes In Support of Stakeholder InterestsGlobeNewsWire • 10/15/20
Myriad (MYGN) Down 0.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/12/20